Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,785,864
-
Share change
-
-3,748,519
-
Total reported value
-
$31,490,677
-
Put/Call ratio
-
77%
-
Price per share
-
$0.88
-
Number of holders
-
51
-
Value change
-
-$19,534,369
-
Number of buys
-
24
-
Number of sells
-
59
Institutional Holders of AUGMEDIX INC - COM (AUGX) as of Q2 2024
As of 30 Jun 2024,
AUGMEDIX INC - COM (AUGX) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,785,864 shares.
The largest 10 holders included
Redmile Group, LLC, Samjo Management, LLC, CITADEL ADVISORS LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, Balyasny Asset Management L.P., Rhenman & Partners Asset Management AB, G2 Investment Partners Management LLC, and LUMINUS MANAGEMENT LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.